Sign in
4

Changes in Ownership

Relay Therapeutics, Inc. Filed Acc 0001209191-23-004127

President and CEO sold 84,000 shares at an average $20.37 ($1,711,360)

  • President and CEO acquired 84,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Patel Sanjiv President and CEO 2023-01-17 Option exercise +28,000 $5.04 $141,120 282,554 D: show line 1 in the form
Patel Sanjiv President and CEO 2023-01-17 Sale −28,000 $20.23 $566,440 254,554 D: show line 2 in the form
Patel Sanjiv President and CEO 2023-01-18 Option exercise +28,000 $5.04 $141,120 282,554 D: show line 3 in the form
Patel Sanjiv President and CEO 2023-01-18 Sale −28,000 $20.87 $584,360 254,554 D: show line 4 in the form
Patel Sanjiv President and CEO 2023-01-19 Option exercise +28,000 $5.04 $141,120 282,554 D: show line 5 in the form
Patel Sanjiv President and CEO 2023-01-19 Sale −28,000 $20.02 $560,560 254,554 D: show line 6 in the form
Open-market sales · 84,000 sh · avg $20.37 · $1,711,360

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Patel Sanjiv President and CEO 2023-01-17 Option exercise · Stock Option (Right to Buy) −28,000 666,779 D: show line 7 in the form
Patel Sanjiv President and CEO 2023-01-18 Option exercise · Stock Option (Right to Buy) −28,000 638,779 D: show line 8 in the form
Patel Sanjiv President and CEO 2023-01-19 Option exercise · Stock Option (Right to Buy) −28,000 610,779 D: show line 9 in the form
Patel Sanjiv President and CEO 2023-01-17 Grant or award · Stock Option (Right to Buy) +701,680 701,680 D: show line 10 in the form
Patel Sanjiv President and CEO 2023-01-17 Grant or award · Stock Option (Right to Buy) +701,680 701,680 D: show line 11 in the form
Loading xslF345X03/doc4.xml…